Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved
Author:
Publisher
Elsevier BV
Subject
Molecular Biology,Biochemistry,Biophysics
Reference42 articles.
1. New drug candidate targeting the 4A1 orphan nuclear receptor for medullary thyroid cancer therapy;Zhang;Molecules,2018
2. Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS;Zou;Redox Biol.,2018
3. Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line;Perna;BMC Compl. Alternative Med.,2018
4. Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes;Tang;World J. Surg. Oncol.,2018
5. Multikinase inhibitors: a new option for the treatment of thyroid cancer;Gild;Nat. Rev. Endocrinol.,2011
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Alkaloid-based modulators of the PI3K/Akt/mTOR pathway for cancer therapy: Understandings from pharmacological point of view;Chemico-Biological Interactions;2024-10
2. The small phytomolecule resveratrol: A promising role in boosting tumor cell chemosensitivity;Pharmacia;2024-06-10
3. Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy;Pharmacological Research;2024-05
4. Promising Approaches in Plant-Based Therapies for Thyroid Cancer: An Overview of In Vitro, In Vivo, and Clinical Trial Studies;International Journal of Molecular Sciences;2024-04-18
5. Research progress of plant-derived natural products in thyroid carcinoma;Frontiers in Chemistry;2024-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3